Answer & Explanation:
The requirement for extensive testing of medicines by the federal government affects drug manufacturers and consumers in several ways. On the one hand, drug manufacturers have to spend significant amounts of time and money to conduct clinical trials and obtain regulatory approval for their products. This can result in higher prices for medicines, as companies pass on the cost of testing and development to consumers. On the other hand, the requirement for testing ensures that medicines are safe and effective before they are made available to the public, which can help to prevent harmful side effects and save lives.
I personally agree with this policy because it helps to ensure that medicines are safe and effective before they are sold to the public. Without such requirements, drug manufacturers might be inclined to rush products to market without adequate testing, which could put consumers at risk. However, I also recognize that the cost of testing and development can be a significant burden for drug manufacturers, particularly for smaller companies or for medicines that treat rare diseases. Therefore, I think it is important for governments to provide funding and support to facilitate the development of new medicines while still maintaining rigorous safety standards.